The rise of Viagra and its impact on the medicinal landscape presents a intricate question for shareholders. While the initial sales statistics were astounding, the patent has expired, leading to a flood of off-brand https://laylashxj847519.look4blog.com/79216349/the-blue-pill-and-the-pharmaceutical-industry-a-speculative-opportunity